DeepState
Multi-Strategy, Quant and Fundamental
- Joined
- 30 March 2014
- Posts
- 1,615
- Reactions
- 81
It's not just about women. There's something in the water about the men as well.
http://www.abc.net.au/news/2013-02-05/more-tv-means-less-sperm-study/4502820
Coupled with women starting to have kids in their 30s... when their male parters are likely to be in the 30s as well. Chances are the men exercise would also be less in that age cohert.
Hi Retired Young
Are the charts your own analysis? If so I am very impressed. Is the data all publically available from the ABS or did you have to spend a long time digging it all out?
Great post by the way.
Hi CC. All of the underlying data shown was sourced from the ABS and the MVF prospectus. Medicare stuff comes from Dept of Human Services and household confidence measures come from ABS and other surveys like Westpac-MI. You need to mash these all together to arrive at base rates for unit demand. That's just a step to determining line #1 (Revenue) of the valuation, of course.
It's not hard to dig up after wasting days figuring out what you need and what is available!
the biggest issue relates to the government rebates. currently IVF treatment is rebated heavily. will the government continue to support these treatments?
certainly Australia is a "pro-natalist" country. most of its policies are centred around trying to increase the population.
-immigration
-baby bonus payments
-paid maternity leave
-family tax benefits
etc etc
whilst funding for IVF is significant, economic modelling has shown that above all other policies aimed at increased the birth rate, IVF is the one that provides a significant return on investment. i.e., you are creating a life where one was not otherwise going to be achieved (for that couple) and over the course of that new life that IVF has created, the country gets back what it paid for in helping create it.
Yep, it's the single biggest event risk. The management view on this is that is represents less than 2% of Medicare expenditure and would lose votes in middle Australia worth more than any budgetary saving.
With regards to the price sensitivity of IVF. There would be few couples who accept childlessness due to the cost of IVF. Where price has an impact is on how quickly they are willing to resort to IVF type treatments. If it's cheap enough some may be willing to go down the path after 6-8months of not being able to fall pregnant, but if it's a bit more expensive then they may have to wait 2yrs etc.
I was surprised to see how pro-cyclic IVF demand is. I would not have thought it would be so large.
I was surprised to see how pro-cyclic IVF demand is. I would not have thought it would be so large.
Hi RY
I was shocked too! I did a little research. From 2009/2010 it appears a new item 13201 was added which appears to be identical to 13200 (See here). When the two are added together it's not anywhere near as cyclical. Not sure if they should be added though or why they have split them into two reporting codes! Sorry, I would have put it into Excel but I'm on a Mac and I suck at using their spreadsheet program.
Ahh... there's a simple explanation to many things! Great work.
http://www.medicareaustralia.gov.au/provider/pbs/drugs1/ivf-gift.jsp
13200 refers to the first cycle. 13201 refers to subsequent cycles.
Median number of efforts per client is now three. With improved technology, that figure has downside risk
I think your points are very valid.
I would be interested to see what the effects of GFC type events have on the birth rate in general.
ie, during suboptimal economic conditions where consumer confidence is affected are people concerned about their ability to pay for the upbringing of children.
I would say, to a point, that this plays a factor.
I dont think its too much of a stretch to say that in times of economic despair, such as the GFC, where people lose their jobs or face a significant income cut that they would think twice about having children, whether that be via natural means or via IVF. The fact that IVF costs money would certainly amplify the potential effect on that cohort of the population (i.e. those considering fertility treatment).
the other thing i'll mention with regards to your graphs, there may be other factors that have played a part. for example, the medicare safety net. if that was risen at some stage during that graph, that would have had an effect on the demand for fertility treatments.
and one final thing. i suspect that the demand for fertility treatments from "first time" patients may not actually change that much. i.e., patients that have no children and desperately want a child and have yet to have any fertility treatment. my guess is that those couples would, for the most part, go ahead and pay what it takes (to a point) to make their dreams come true. so for that cohort of patients, they may not be so price sensitive as the graph suggests. but, for patients that have already had 3 cycles of IVF without success, have sunk thousands of dollars on other things such as scans, blood tests or surgery, the thought of spending another couple thousand dollars or so on another cycle of IVF probably doesn't sound too appealing during times of sub-optimal economic conditions. my guess its this cohort of patients that might say "enough is enough". its this cohort that may be quite price sensitive.
but people need to remember, the cost of fertility treatment is a tiny fraction of the cost of having a baby and bringing up a child. so to me, it makes no sense that people would not want fertility treatment because of the cost. but as you've shown there are certainly people out there that are willing to either go ahead with treatment or not based on the cost.
.
So, both figures have value depending on purpose. I used #13200 because we were talking about efforts to get pregnant and this was the closest figure I can get to it. The actual number of clients starting IVF from scratch would be lower than the figures shown and the real cyclicality in the figure would be more pronounced than what was shown.
I've made no progress on this baby.
The issue though is that if 13201 didn't exist before 1/1/2010 and was just bundled into 13200, which is my interpretation, it makes 13200 pretty useless as a time series to compare pre and post 2010. Doesn't it?
John, I hope that you will see fit to continue to probe like this. I find it extremely valuable.
There was a Medicare cap on IVF that was introduced in 2010. There are ongoing squeezes already baked in for the Medicare Extended Safety net. The introduction of this cap can only be a negative influence on IVF. It coincides with the 'confidence/ability-to-fund' indicator (ANZ job ads). Hence, we cannot break it apart easily.
MVF-AU has been crushed following an update of trading. A good part of the reason for that was competition in SA. A local operator was discounting and pulled a chunk of clients away. I can tell you that Primary Health is also offering a bulk-billed service which is in ramp up. Price clearly affects the buying decisions. Sydney IVF has halted price increases as the 2015 round of Medicare limits bites.
Your question about births is fantastic. Here are the stats:
View attachment 60658
Births show high resilience to changes in economic circumstance.
The natural extension of this is that IVF is affected by confidence and prices. It looks like the number of people wanting IVF changes rather a lot because of it. it is likely that there was some pull forward of demand ahead of the cap implementation, boosting the 2009/10 figure and troughing the 2010/11 figure. This would make the confidence indicator a better explanatory variable too.
This helps me to gauge the extent of potential for price competition to impact outcomes in a market with low/moderate barriers to entry in which new entrants are happy to buy market share. It's not good. Excess profits are not likely to be sustained. Competition is centered around geography, but I'd drive a couple of suburbs more to save $2k and I liked the doctors equally (how would I know?). It also demonstrates that confidence is a large influence in choice to pursue IVF. Although it is a relatively small outlay compared to the cost of raising a child, the buying decision is clearly much more sensitive to the price of the process than might be imagined.
Monash IVF (MVF) has announced the acquisition of the Fertility East business in Bondi Junction in Sydney. MVF has paid A$3m (plus A$500,000 subject to meeting performance hurdles). Fertility East has revenue of A$5m and will be EPS accretive immediately.
The purchase price will be funded from a mix of debt and cash.
MVF has struggled since listing and this should help to start re-rating the stock. The acquisition is in line with MVF's strategy and helps tighten up the market.
Both listed players in the IVF space, MVF and Virtus Health (VRT), have seen share price weakness with lower domestic IVF cycle numbers creating some uncertaintly. However we think the IVF market is tightening up - these two companies dominate the market place and offer independent fertility specialists attractive corporatisation models.
We have a positive view on MVF and think the fundamentals are attractive. We retain our Add recommendation with a share price target of A$2.01.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?